BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38457229)

  • 1. Clinicopathological and genomic features of superficial esophageal squamous cell carcinomas in nondrinker, nonsmoker females.
    Fukuhara M; Urabe Y; Nakahara H; Ishikawa A; Ishibashi K; Konishi H; Mizuno J; Tanaka H; Tsuboi A; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Hayes CN; Oka S
    Cancer Med; 2024 Feb; 13(4):e7078. PubMed ID: 38457229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
    Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
    Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel genomic alteration in superficial esophageal squamous cell neoplasms in non-smoker non-drinker females.
    Onozato Y; Sasaki Y; Abe Y; Sato H; Yagi M; Mizumoto N; Kon T; Sakai T; Ito M; Umehara M; Koseki A; Ueno Y
    Sci Rep; 2021 Oct; 11(1):20150. PubMed ID: 34635759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immuno-genomic analysis reveals eosinophilic feature and favorable prognosis of female non-smoking esophageal squamous cell carcinomas.
    Okawa Y; Sasagawa S; Kato H; Johnson TA; Nagaoka K; Kobayashi Y; Hayashi A; Shibayama T; Maejima K; Tanaka H; Miyano S; Shibahara J; Nishizuka S; Hirano S; Seto Y; Iwaya T; Kakimi K; Yasuda T; Nakagawa H
    Cancer Lett; 2024 Jan; 581():216499. PubMed ID: 38013050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADH1B and ALDH2 are associated with metachronous SCC after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Kagemoto K; Urabe Y; Miwata T; Oka S; Ochi H; Kitadai Y; Tanaka S; Chayama K
    Cancer Med; 2016 Jul; 5(7):1397-404. PubMed ID: 27038040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma.
    Fukuhara T; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
    J Clin Gastroenterol; 2010 Feb; 44(2):e27-33. PubMed ID: 19730116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of superficial esophagus squamous cell carcinoma according to alcohol-degrading enzyme ADH1B and ALDH2 genotypes.
    Tajiri A; Ishihara R; Sakurai H; Nakamura T; Tani Y; Inoue T; Matsueda K; Miyake M; Waki K; Fukuda H; Shichijo S; Maekawa A; Kanesaka T; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Matsunaga T
    J Gastroenterol; 2022 Sep; 57(9):630-639. PubMed ID: 35788888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Genomic Analysis of Patients with Short Survival after Surgery for Esophageal Squamous Cell Carcinoma.
    Gao L; Guo RY; Lu H; Shi ZH; Liu JF
    Dig Dis; 2023; 41(3):353-361. PubMed ID: 36412562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
    Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
    World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential roles of gastroesophageal reflux in patients with superficial esophageal squamous cell carcinoma without major causative risk factors.
    Fukuchi T; Hirasawa K; Sato C; Makazu M; Kaneko H; Kobayashi R; Nishio M; Ikeda R; Sawada A; Ozeki Y; Sugimori M; Inayama Y; Tateishi Y; Maeda S
    J Gastroenterol; 2021 Oct; 56(10):891-902. PubMed ID: 34426869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of superficial squamous cell carcinoma developing in the head and neck region in patients with esophageal squamous cell carcinoma.
    Katada C; Muto M; Nakayama M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Yamashita K; Nemoto M; Shibata T; Masaki T; Okamoto M; Koizumi W
    Laryngoscope; 2012 Jun; 122(6):1291-6. PubMed ID: 22674532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with the presence of multiple Lugol-voiding lesions in patients with esophageal squamous-cell carcinoma.
    Katada C; Muto M; Tanabe S; Higuchi K; Sasaki T; Azuma M; Ishido K; Katada N; Sakuramoto S; Yamashita K; Masaki T; Nakayama M; Okamoto M; Koizumi W
    Dis Esophagus; 2014 Jul; 27(5):457-62. PubMed ID: 23009284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome wide copy number analyses of superficial esophageal squamous cell carcinoma with and without metastasis.
    Wang P; Shan L; Xue L; Zheng B; Ying J; Lu N
    Oncotarget; 2017 Jan; 8(3):5069-5080. PubMed ID: 27974698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
    Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
    Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
    Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
    Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blue laser imaging identifies endoscopic findings corresponding to metachronous esophageal squamous cell carcinoma.
    Azuma Y; Dohi O; Naito Y; Yasuda T; Yoshida T; Ishida T; Kitae H; Matsumura S; Doi T; Hirose R; Inoue K; Yoshida N; Kamada K; Uchiyama K; Takagi T; Ishikawa T; Konishi H; Nishimura A; Kishimoto M; Itoh Y
    Esophagus; 2022 Apr; 19(2):278-286. PubMed ID: 34773554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
    Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
    Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural course of lugol-voiding lesions in patients with superficial esophageal squamous cell carcinoma.
    Fukuhara T; Hiyama T; Tanaka S; Oka S; Yoshihara M; Arihiro K; Chayama K
    Digestion; 2010; 82(1):60-5. PubMed ID: 20203512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a risk model for the development of metachronous squamous cell carcinoma after endoscopic resection of esopahageal squamous cell carcinoma.
    Urabe Y; Kagemoto K; Nakamura K; Mizumoto T; Sanomura Y; Oka S; Ochi H; Tanaka S; Chayama K
    Esophagus; 2019 Apr; 16(2):141-146. PubMed ID: 30173282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma.
    Suzuki Y; Kikuchi D; Hoteya S; Okamura T; Ochiai Y; Hayasaka J; Dan N; Mitsunaga Y; Tanaka M; Odagiri H; Nomura K; Yamashita S; Matsui A; Iizuka T
    Digestion; 2021; 102(4):622-629. PubMed ID: 32992320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.